GLP-1 muscle loss: what we know in 2026, and what to do about it
About 30% of the weight a typical GLP-1 patient loses is lean mass, including muscle. The number is real. Whether it matters depends on what you do alongside the medication.
TLDR. About 30 percent of the weight a typical GLP-1 patient loses is lean mass, including muscle. The number is similar to lean-mass loss in bariatric surgery and aggressive calorie restriction, and somewhat higher than slow lifestyle-based weight loss. Whether the muscle loss matters depends on what you do alongside the medication. Protein intake at 1.4 to 1.8 g/kg body weight and resistance training twice weekly preserve most of the lean mass that would otherwise be lost. Patients who lift and eat protein lose more fat and less muscle than patients who do not.
| Fact | Value | Source | Verified |
|---|---|---|---|
| Typical lean mass loss on GLP-1 | ~30% of total weight lost | STEP-1 DXA substudies; obesity-medicine data | May 2026 |
| Lean mass loss on bariatric surgery | ~25 to 30% of total weight lost | Bariatric outcome data | May 2026 |
| Protein intake target during weight loss | 1.4 to 1.8 g/kg body weight | ISSN position stand | May 2026 |
| Resistance training cadence | Twice weekly minimum to preserve lean mass | Sports medicine guidelines | May 2026 |
| Lean mass preservation effect of training | 50 to 70% reduction in lean-mass loss | Exercise + weight loss meta-analyses | May 2026 |
| Sarcopenia risk in older GLP-1 patients | Higher; dedicated screening recommended | Obesity medicine senior-care guidance | May 2026 |
Every weight-loss intervention causes some lean-mass loss along with fat loss. Diet alone causes it. Bariatric surgery causes it. GLP-1 causes it. The relevant question is not whether muscle is lost (yes) but how much, and what you can do to keep more of it.
Here is what the trial data and the metabolic literature actually say as of 2026.
The trial-level numbers
STEP-1 (Wegovy) and SURMOUNT-1 (Zepbound) used DXA body-composition substudies in subsets of trial participants. The headline finding:
- Mean total weight loss: 15% (Wegovy) and 20% (Zepbound) of starting body weight
- Of that loss: roughly 30-40% was lean mass (which includes muscle, organ tissue and water), 60-70% was fat mass
- The lean-to-fat ratio of loss is similar to surgical weight loss and to severe calorie restriction
So a 200-pound patient who loses 30 pounds on Wegovy will typically lose roughly 10 pounds of lean mass and 20 pounds of fat mass. The exact split varies by age, sex, baseline muscle mass and what the patient does during treatment.
What "lean mass" actually means
Lean mass on DXA is not just muscle. It includes:
- Skeletal muscle (the visible muscle you would identify as "muscle"). Most of the practical concern.
- Organ tissue (liver, intestines, kidneys). Some of this loss is desirable; fatty liver and visceral fat around organs shrink when you lose weight, and that shrinkage shows up as "lean mass loss" on DXA.
- Body water. Glycogen-bound water releases in the first 2-4 weeks; this is the dramatic "drop 8 pounds in a week" effect early on. Almost none of it is actually muscle.
- Bone-adjacent connective tissue.
So the 30-40% lean-mass loss number overstates pure muscle loss. The studies that have separated skeletal muscle from total lean mass (using MRI or CT) suggest skeletal muscle accounts for about 15-25% of total weight lost on GLP-1, not 30-40%. Still real, but less alarming than the lean-mass headline.
Who loses the most muscle
Three patient profiles lose disproportionately more muscle:
- Older adults (50+): age-related sarcopenia is already underway. GLP-1 accelerates it if no resistance training is done.
- Inactive patients: muscle that is not used is preferentially catabolised during a calorie deficit. The body keeps what it needs.
- Low-protein eaters: protein intake below 0.8 g/kg of body weight during weight loss is associated with higher muscle loss across every weight-loss intervention.
If you are 45, sedentary and eating high-carb / low-protein during GLP-1 treatment, you will lose more muscle than the trial means. If you are 30, lift weights twice a week and eat 1.2 g/kg protein, you will lose less.
What actually helps
Resistance training: the single biggest lever
Two to three sessions per week of resistance training (free weights, machines or bodyweight done to near-failure) reduces lean-mass loss by 30-50% across every weight-loss study. The mechanism: signalling muscle that it is being used, which the body interprets as "keep this tissue".
You don't need to be a bodybuilder. The minimum effective dose appears to be 6-8 working sets per major muscle group per week, distributed across 2-3 sessions. That is roughly 45 minutes twice a week of compound exercises (squat, hinge, push, pull). If you are not currently lifting, this is the single most cost-effective protective intervention.
Protein intake: 1.0 to 1.2 g per kg of target body weight
Target body weight, not current body weight. If you weigh 220 pounds and want to weigh 180, calculate protein from 180 (about 82 kg, so 82-98 g of protein per day).
This usually requires conscious effort during GLP-1 treatment because reduced appetite makes patients undereat protein. Practical sources: Greek yogurt (15-20g per cup), cottage cheese (25g per cup), chicken breast (30g per 4oz), protein shakes (20-30g per scoop). Spread across three feedings of 25-35g each, not all at one meal.
Creatine monohydrate: cheap, well-studied, no downside
3-5g per day of creatine monohydrate. The evidence for creatine preserving muscle during calorie restriction is strong. The cost is roughly $0.10 per day. The only side effect at the standard dose is mild water retention (which shows up as scale weight, not as visible swelling).
Don't crash the deficit
Patients who pair aggressive caloric restriction with GLP-1 lose more muscle than those who let the medication do the work. The medication itself is creating the deficit; adding 800 calories of restriction on top of it pushes the body into preservation mode and accelerates lean-mass loss. Eat to satiety (which is the new lower satiety driven by the medication).
The clinically meaningful question
Is the muscle loss enough to affect function, or is it cosmetic?
In trial populations, GLP-1 weight loss did NOT cause clinically meaningful sarcopenia (functional muscle weakness) in most patients. Grip strength, walking speed and stair-climb tests were preserved or improved (improved because reduced body weight makes the same absolute strength functionally more powerful).
In older patients with already-low baseline muscle (defined as appendicular lean mass below 7.0 kg/m² in men, 5.4 in women), GLP-1 weight loss CAN tip them into clinical sarcopenia. For this group, the recommendation from obesity-medicine guidelines is to either: pair GLP-1 with structured resistance training or to target slower rates of weight loss by using a lower maintenance dose.
For the average 35-year-old at BMI 32, the muscle loss is real, manageable and not clinically dangerous. Add resistance training, eat protein and the math works out fine.
Programs that integrate exercise programming
Form Health and Knownwell have integrated exercise prescribing in their model. Calibrate emphasises behavioural coaching that includes exercise habits. Most cash-pay compounded programs do not include exercise programming; that is on you.
See the month-by-month timeline for when muscle loss is most acute (months 2-6 of the active loss phase) and the maintenance guide for the slower lean-mass dynamics once you reach goal weight.
Frequently asked questions
How much muscle do I lose on a GLP-1?
Roughly 30 percent of total weight lost is lean mass, of which muscle is the largest component. For a patient who loses 50 pounds, that means about 15 pounds of lean mass and 35 pounds of fat. The ratio is similar to bariatric surgery and aggressive calorie restriction; it is higher than the ratio in slow lifestyle weight loss but the absolute fat loss is much larger.
Does muscle loss matter clinically?
It depends on the patient. For most patients in the 30 to 60 age range with normal baseline muscle mass, the lean-mass loss is well within the range that bodies tolerate. For older patients, patients with low baseline muscle (sarcopenia), or athletes optimizing performance, the loss matters more. DXA scans before and during treatment can quantify the change.
Can I prevent muscle loss while on GLP-1?
Not fully, but you can reduce it substantially. Protein intake at 1.4 to 1.8 g/kg body weight per day and resistance training twice weekly preserve roughly 50 to 70 percent of the lean mass that would otherwise be lost. The combination matters more than either alone.
How much protein should I eat on a GLP-1?
1.4 to 1.8 g/kg body weight per day, or roughly 100 to 130 g/day for most adults. This is higher than the standard 0.8 g/kg RDA but well within the safe range. GLP-1 medication reduces appetite, which means hitting the protein target deliberately matters: pick lean protein at every meal, use protein shakes if appetite is low.
What kind of resistance training works?
Compound lifts (squat, deadlift, row, press, pull-up variations) twice weekly with 6 to 12 reps and progressive load. The mechanism is mechanical tension on muscle, which signals retention even in a calorie deficit. Bodyweight training works if loaded progressively. Walking and cardio do not preserve muscle the same way.